Why Hemophilia Patients Could Pay $1.5 Million For Gene Therapy – Investor’s Business Daily
|
Why Hemophilia Patients Could Pay $1.5 Million For Gene Therapy
Investor’s Business Daily Leerink analyst Joseph Schwartz boosted his projections for hemophilia gene therapies to $1.5 million from earlier assumptions for $350,000-$500,000 per patient. Some treatments could go as high as $2 million per patient on a gross basis, he said … |
